Darmstadt-based German multinational science and technology company, Merck KGaA, is to acquire Exelead, a US-based biopharmaceutical CDMO for around US$780m in cash. The acquisition will strengthen the CDMO offering for…
Darmstadt-based German multinational science and technology company, Merck KGaA, is to acquire Exelead, a US-based biopharmaceutical CDMO for around US$780m in cash. The acquisition will strengthen the CDMO offering for…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


